Newspaper publication of unaudited standalone and consoldiated financial results for the quarter ended June 30,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26) in a newspaper, as required under SEBI and BSE listing rules. This is a compliance disclosure confirming that the results, which were already filed with the stock exchanges, have been published in a widely circulated newspaper. No specific financial numbers such as revenue, profit, or margins are provided in this particular filing. Shareholders can refer to the detailed results announcement previously submitted to the exchanges for the actual financial performance figures.
This is a routine regulatory compliance filing and does not contain new financial information beyond what was already reported. It is unlikely to have any material impact on the stock price or shareholder decisions.